Opportunity
SAM #75N98026Q00674
12-Month OEM Service Contract for GeoMx Digital Spatial Profiler (DSP) Instrument
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
June 22, 2026
Respond By
July 02, 2026
Identifier
75N98026Q00674
NAICS
811219, 811210, 334516
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH), is seeking a 12-month preventive maintenance and service contract for its GeoMx Digital Spatial Profiler (DSP) instrument. - Government Buyer: - National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH - Contact: Dr. Resat Cinar - OEMs and Vendors: - Bruker Spatial Biology, Inc. (sole source OEM for GeoMx DSP) - Nanostring (original manufacturer of GeoMx DSP platform) - Products/Services Requested: - Annual preventive maintenance and service contract for GeoMx DSP instrument - Includes three planned preventive maintenance visits - Emergency onsite service - OEM-certified parts replacement - Software updates - Unlimited technical telephone support - Unique/Notable Requirements: - Service must be provided by the OEM (Bruker Spatial Biology, Inc.) - Support is critical for ongoing research in tissue heterogeneity and disease mechanisms - Instrument is used by multiple labs for spatial profiling of RNA and protein expression - No specific part numbers provided; contract covers comprehensive service for the instrument
Description
We purchased the GeoMx Digital Spatial Profiler (DSP) instrument to study tissue heterogeneity and the complexity of microenvironments in the spatial context related to alcohol-induced organ injury and in various fibrosis models. GeoMx DSP is the only spatial biology platform that non-destructively profiles the expression of RNA and protein from distinct tissue compartments and cell populations with an automated and scalable workflow that integrates with standard histology staining. This technique will help us discover novel biomarkers for disease severity, understand disease mechanisms and progression, uncover drug mechanisms of action, and study preclinical models. Currently, multiple labs at NIAAA plan to use this instrument for their ongoing projects.